Bajaj Healthcare Ltd

Bajaj Healthcare Ltd

₹ 292 0.81%
28 Mar - close price
About

Established in the year 1993, Bajaj Healthcare Ltd is an estalished player in the Indian Pharmacuetical Industry and fastest growing mid-cap pharmaceutical companies in India.[1]

It is a bulk drug manufacturer manufacturing and supply of various Active Pharmaceutical Ingredients (API's), Amino acids and Nutritional supplements for Pharmaceuticals, Neutraceuticals, Food industries. [2]

Key Points

Product Portfolio
The Co. is into manufacturing and supply of API's, Intermediates, Formulations and Impurities. [1]
With 6 API manufacturing facilities spread across different states, API contributes around 90% to the overall revenue mix. It has a strong presence in more than 50 countries through exports of API's with an aggregate manufacturing capacity of 730 MT per month. [2]

  • Market Cap 807 Cr.
  • Current Price 292
  • High / Low 513 / 245
  • Stock P/E 28.0
  • Book Value 115
  • Dividend Yield 0.34 %
  • ROCE 11.9 %
  • ROE 12.4 %
  • Face Value 5.00

Pros

Cons

  • Company might be capitalizing the interest cost
  • Debtor days have increased from 92.4 to 123 days.
  • Working capital days have increased from 146 days to 204 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
132.18 185.69 150.91 167.57 175.71 163.79 195.32 132.57 154.11 129.74 101.21 108.57
97.56 152.20 121.95 136.75 150.50 139.33 160.89 102.13 132.08 108.00 82.27 89.04
Operating Profit 34.62 33.49 28.96 30.82 25.21 24.46 34.43 30.44 22.03 21.74 18.94 19.53
OPM % 26.19% 18.04% 19.19% 18.39% 14.35% 14.93% 17.63% 22.96% 14.29% 16.76% 18.71% 17.99%
2.15 0.68 0.12 0.20 0.45 -1.66 -4.79 -5.63 -6.84 -55.02 -7.36 -6.92
Interest 2.15 2.79 2.50 2.84 4.49 2.58 3.64 5.37 5.97 8.75 8.26 6.65
Depreciation 4.43 4.13 4.41 4.86 4.24 4.08 4.00 4.43 4.69 6.31 6.66 7.35
Profit before tax 30.19 27.25 22.17 23.32 16.93 16.14 22.00 15.01 4.53 -48.34 -3.34 -1.39
Tax % 29.51% 29.50% 22.19% 25.21% -3.25% 25.53% 25.64% 26.38% 20.53% 0.25% -3.59% -57.55%
21.28 19.22 17.25 17.45 17.47 12.02 16.36 11.05 3.59 -48.21 -3.46 -2.20
EPS in Rs 7.71 6.96 6.25 6.32 6.33 4.36 5.93 4.00 1.30 -17.47 -1.25 -0.80
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
142 171 205 218 223 231 327 370 410 657 680 673 494
130 158 186 189 193 200 288 327 362 521 561 566 411
Operating Profit 11 13 19 29 30 31 39 43 48 136 119 107 82
OPM % 8% 7% 9% 13% 14% 13% 12% 12% 12% 21% 17% 16% 17%
0 0 0 0 0 2 2 1 7 7 1 2 -76
Interest 5 6 7 8 8 8 8 8 7 8 13 23 30
Depreciation 6 8 9 9 9 11 11 11 12 16 18 27 25
Profit before tax 1 -2 3 12 14 14 23 24 36 119 90 58 -49
Tax % 38% 31% 40% 37% 39% 43% 33% 33% 30% 30% 20% 26%
1 -1 2 8 8 8 15 16 25 83 71 43 -50
EPS in Rs 0.72 -1.18 2.19 8.34 3.04 2.83 5.50 5.91 9.14 30.11 25.87 15.59 -18.22
Dividend Payout % 0% 0% 0% 0% 0% 0% 5% 0% 0% 5% 6% 6%
Compounded Sales Growth
10 Years: 15%
5 Years: 16%
3 Years: 18%
TTM: -26%
Compounded Profit Growth
10 Years: 46%
5 Years: 23%
3 Years: 19%
TTM: -59%
Stock Price CAGR
10 Years: %
5 Years: 22%
3 Years: 7%
1 Year: 1%
Return on Equity
10 Years: 19%
5 Years: 21%
3 Years: 23%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 2 2 2 2 7 7 7 7 14 14 14 14 14
Reserves 27 26 28 78 82 92 107 122 164 245 315 354 302
Preference Capital 2 2 2 2 0 0 0 0 0 0 0 0
61 70 70 69 81 75 87 81 91 181 257 415 357
32 33 45 40 39 45 68 57 74 86 136 119 165
Total Liabilities 121 131 145 189 209 219 268 267 343 526 721 901 838
46 54 56 108 130 128 127 128 162 208 270 366 245
CWIP 13 5 3 1 1 0 2 1 5 57 52 22 14
Investments 0 0 0 0 0 0 0 0 5 0 0 0 0
63 72 87 79 78 91 140 137 170 260 399 514 579
Total Assets 121 131 145 189 209 219 268 267 343 526 721 901 838

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
9 14 17 28 25 22 17 25 21 44 1 -22
-15 -8 -9 -17 -31 -8 -12 -13 -28 -109 -75 -93
6 -7 -8 -11 5 -13 2 -13 3 75 62 132
Net Cash Flow 0 -0 1 -0 -0 0 7 -0 -4 10 -12 16

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 90 95 98 86 70 83 90 77 88 55 99 123
Inventory Days 58 43 51 50 56 45 57 45 54 94 143 191
Days Payable 60 51 68 63 46 51 74 45 80 67 94 78
Cash Conversion Cycle 87 87 81 73 80 78 73 77 62 82 148 237
Working Capital Days 62 71 62 52 52 58 61 66 76 90 142 204
ROCE % 7% 5% 10% 16% 13% 13% 16% 16% 18% 36% 20% 12%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
67.26% 67.26% 67.26% 67.26% 67.26% 67.30% 67.30% 67.42% 67.49% 67.49% 67.69% 67.73%
0.00% 0.00% 0.34% 0.32% 0.38% 0.32% 0.09% 0.94% 0.78% 0.69% 0.66% 0.74%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.34% 0.34% 0.34% 0.43% 0.48%
32.74% 32.74% 32.39% 32.42% 32.36% 32.38% 32.62% 31.30% 31.38% 31.48% 31.22% 31.06%
No. of Shareholders 7,23613,28326,70732,30930,72330,90929,76926,93026,03727,32228,00829,626

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents